Jennifer J. Rhodes, EVP, CHIEF LEGAL OFFICER, Secretary at ACADIA PHARMACEUTICALS INC (ACAD), sold 6,950 shares at $23.38 ($162K) on 2026-02-09, disclosed to the SEC on 2026-02-10.
Scheduled sale ($162k) by EVP, CHIEF LEGAL OFFICER, Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| ANGN | SELL | 2021-11-16 | $2K | — | Filing → |
| ANGN | SELL | 2021-10-15 | $4K | — | Filing → |
| ANGN | SELL | 2021-09-15 | $5K | — | Filing → |